Cymabay Therapeutics, Inc.
CBAY
Revenue
0.00
▼-31.02M▼-100.00%
3 Months ChangeAssets
434.69M
▼-16.36M▼-3.63%
3 Months ChangeLiabilities
142.43M
▲17.57M▲14.07%
3 Months ChangeFree Cash Flow
6.24M
▲31.60M▲124.59%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-03-22
Form 8-K
ID: 0001193125-24-074701
2024-03-20
Form 8-K
ID: 0001193125-24-072728
2024-02-12
Form 8-K
ID: 0001193125-24-031185
2024-01-26
Form 8-K
ID: 0001193125-24-016706
2023-12-21
Form 8-K
ID: 0001193125-23-301176
2023-12-13
Form 8-K
ID: 0001193125-23-294330
2023-11-07
Form 10-Q
ID: 0001193125-23-272401
2023-09-12
Form 8-K
ID: 0001193125-23-233447
2023-09-11
Form 8-K
ID: 0001193125-23-231906
2023-08-10
Form 10-Q
ID: 0001193125-23-209009